Literature DB >> 25545737

Anticipated increase in the number of patients who require dialysis treatment among the aging population of Japan.

Minako Wakasugi1, Junichiro James Kazama2, Ichiei Narita3.   

Abstract

The aging population is anticipated to have a large impact on the number of incident dialysis patients, as the risk of end-stage kidney disease increases with age. This study aimed to examine trends in the sex- and age-specific incidence rates of dialysis between 2008 and 2012, and to assess the impact of population aging on the number of incident dialysis patients over the next decade in Japan. Incidence was calculated using published data and Japan's population statistics. The 2012 incidence was extrapolated, and projected future demographic changes within the Japanese population were used to estimate the number of incident dialysis patients in 2020 and 2025. As a general trend, the sex- and age-specific incidence rates of dialysis decreased gradually between 2008 and 2012, except among men aged ≥80 years. The total number of incident dialysis patients was projected to increase by 12.8% from 36 590 in 2012 to 41 270 in 2025. Greater increases were observed in the oldest age group (≥85 years). In 2025, the number of incident dialysis patients in this group was projected to increase by 92.6% in men and 62.2% in women. This study shows the number of patients who initiate dialysis treatment is projected to increase over the next decade in Japan due to aging of the population. Effective strategies are needed to offset the challenges faced by the aging population, with a particular focus on octogenarians and older, given the notable proportion of patients requiring dialysis treatment in the future.
© 2014 The Authors. Therapeutic Apheresis and Dialysis © 2014 International Society for Apheresis.

Entities:  

Keywords:  Aging; Dialysis; Epidemiology; Incidence; Population projection

Mesh:

Year:  2014        PMID: 25545737     DOI: 10.1111/1744-9987.12266

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  6 in total

1.  Projecting ESRD Incidence and Prevalence in the United States through 2030.

Authors:  Keith P McCullough; Hal Morgenstern; Rajiv Saran; William H Herman; Bruce M Robinson
Journal:  J Am Soc Nephrol       Date:  2018-12-17       Impact factor: 10.121

2.  Forecasting the Incidence and Prevalence of Patients with End-Stage Renal Disease in Malaysia up to the Year 2040.

Authors:  Mohamad Adam Bujang; Tassha Hilda Adnan; Nadiah Hanis Hashim; Kirubashni Mohan; Ang Kim Liong; Ghazali Ahmad; Goh Bak Leong; Sunita Bavanandan; Jamaiyah Haniff
Journal:  Int J Nephrol       Date:  2017-02-28

3.  Telomere shortening in patients on long-term hemodialysis.

Authors:  Yucheng Wang; Siyu Chen; Shi Feng; Cuili Wang; Hong Jiang; Song Rong; Haller Hermann; Jianghua Chen; Ping Zhang
Journal:  Chronic Dis Transl Med       Date:  2021-08-25

4.  Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study.

Authors:  Hiroshi Kataoka; Toshio Mochizuki; Mamiko Ohara; Yuki Tsuruta; Naomi Iwasa; Rie Yoshida; Ken Tsuchiya; Kosaku Nitta; Kenjiro Kimura; Tatsuo Hosoya
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.996

5.  Periodontitis and health-related quality of life in hemodialysis patients.

Authors:  Masanori Iwasaki; Wenche S Borgnakke; Shuji Awano; Akihiro Yoshida; Tomoko Hamasaki; Gou Teratani; Shota Kataoka; Satoko Kakuta; Inho Soh; Toshihiro Ansai; Hidetoshi Nakamura
Journal:  Clin Exp Dent Res       Date:  2016-11-24

6.  Lifetime and age-conditional risk estimates of end-stage kidney disease requiring maintenance dialysis in Japan.

Authors:  Minako Wakasugi; Ichiei Narita
Journal:  Clin Exp Nephrol       Date:  2020-02-10       Impact factor: 2.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.